Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Canada Inspection
/
GlaxoSmithKline Biologicals

CANADA INSPECTION

•GlaxoSmithKline Biologicals•April 20, 2023

Canada Inspection 84922 - GlaxoSmithKline Biologicals - April 20, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This CANADA INSPECTION record concerns GlaxoSmithKline Biologicals, with an inspection on April 20, 2023, covering drugs.

Company: GlaxoSmithKline Biologicals
Inspection Date: April 20, 2023
Product Type: Drugs

Open in Dashboard

ID · d5538cd6-df5c-4b59-a266-dd9400a03819

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

Canada Inspection 84922 - GlaxoSmithKline Biologicals - April 20, 2023 | Global Key Solutions